cobalt has been researched along with Cystadenocarcinoma, Serous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enns, RE; Heath, DD; Howell, SB; Naredi, P | 1 |
1 other study(ies) available for cobalt and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
Topics: Antimony; Antimony Potassium Tartrate; Cadmium; Cisplatin; Cobalt; Cystadenocarcinoma, Serous; Drug Resistance; Drug Screening Assays, Antitumor; Female; Glutathione; Humans; Nickel; Ovarian Neoplasms; Tumor Cells, Cultured; Zinc | 1994 |